Equities researchers at StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO – Get Rating) in a note issued to investors on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance ABIO stock opened at $2.27 on Wednesday. ARCA biopharma has a 12 month low of $1.71 and […]